Ettickan Boopathi

662 citations
27 papers · 463 indexed · h-index 15
Topics
Pharmacogenetics and Drug Metabolism (5 papers)Cancer-related Molecular Pathways (4 papers)Caveolin-1 and cellular processes (3 papers)
Partner nations
United StatesBrazilIndia

In The Last Decade

Ettickan Boopathi

26 papers receiving 457 citations

Peers

Ettickan Boopathi
Comparison fields: 5 of 76
  • Molecular Biology 205
  • Oncology 97
  • Pharmacology 79
  • Cell Biology 70
  • Pulmonary and Respiratory Medicine 68
Replace K Okuhara with:
K Okuhara Japan
M.L. Bernal Spain
Tetsuhiro Horie Japan
Ikumasa Takenaka Japan
Fabien Forcheron France
Yukihiko Seki Japan
Jun-ya Kaimori Japan
Aninda Basu United States
Kotaro Azuma Japan
Ettickan Boopathi relative to K Okuhara Japan K Okuhara's profile →
Citations per field
00.5×
K Okuhara · 1×
Citations per year

Countries citing papers authored by Ettickan Boopathi

Since Specialization
Citations

This map shows the geographic impact of Ettickan Boopathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ettickan Boopathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ettickan Boopathi more than expected).

Fields of papers citing papers by Ettickan Boopathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ettickan Boopathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ettickan Boopathi. The network helps show where Ettickan Boopathi may publish in the future.

Co-authorship network of co-authors of Ettickan Boopathi

This figure shows the co-authorship network connecting the top 25 collaborators of Ettickan Boopathi. A scholar is included among the top collaborators of Ettickan Boopathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ettickan Boopathi. Ettickan Boopathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 12
3 13
4 2
5 7
6 39
7 5
8 20
9 4
10 20
11 6
12 31
13 21
14 32
15 38
16 28
17 17
18 12
19 33
20 18

About Ettickan Boopathi

Ettickan Boopathi is a scholar working on Pharmacology, Urology and Cell Biology, having authored 27 papers that have together received 463 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Cancer-related Molecular Pathways (4 papers) and Caveolin-1 and cellular processes (3 papers). The work is most often cited by research in Pharmacology (79 citations), Urology (47 citations) and Cell Biology (70 citations). Ettickan Boopathi has collaborated with scholars based in United States, Brazil and India. Frequent co-authors include Chellappagounder Thangavel, Ji-Kang Fang, Narayan G. Avadhani, Bernard H. Shapiro, Samuel Chacko, Stephen A. Zderic, Robert B. Den, Alan J. Wein, Sankar Addya and Satish Srinivasan. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cell and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026